Arodoxin Injection 2 mg/ml contains Doxorubicin Hydrochloride, a potent anticancer medicine belonging to the anthracycline class of chemotherapy drugs. It is used to treat a wide range of cancers by slowing or stopping the growth of cancer cells. Doxorubicin is widely used either alone or in combination with other chemotherapy agents as part of comprehensive cancer treatment protocols.

Doxorubicin works by interfering with the DNA of rapidly dividing cancer cells, preventing them from multiplying and leading to their destruction. Because it also affects some healthy rapidly dividing cells, treatment must be carefully monitored by an experienced oncologist.

Arodoxin Injection is administered intravenously in a hospital or specialized oncology setting. The dose and treatment schedule are individualized based on the type of cancer, body surface area, overall health, liver function, and previous chemotherapy exposure.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Doxorubicin Hydrochloride 2 mg/ml

Dosage Form: Intravenous Injection

How Arodoxin Injection Works

Doxorubicin is an anthracycline antibiotic with antineoplastic activity. It works through multiple mechanisms to destroy cancer cells by:

• Intercalating into DNA and disrupting DNA replication
• Inhibiting the enzyme topoisomerase II, preventing DNA repair
• Generating free radicals that damage cancer cells
• Blocking cell division and promoting cancer cell death

These combined actions help slow or stop the progression of various cancers.

Indications

Arodoxin Injection 2 mg/ml is indicated for the treatment of:

• Breast cancer
• Ovarian cancer
• Lung cancer
• Soft tissue and bone sarcomas
• Hodgkin lymphoma
• Non-Hodgkin lymphoma
• Acute leukemias
• Multiple myeloma
• Thyroid cancer
• Bladder cancer
• Other malignancies as determined by an oncologist

It may be used alone or in combination with other chemotherapy medicines depending on the treatment protocol.

Benefits of Arodoxin Injection

• Effective against a broad range of cancers
• Helps slow or stop the growth of cancer cells
• Can be used as part of combination chemotherapy regimens
• Well-established medicine in oncology practice
• Supports improved treatment outcomes when used according to evidence-based protocols

Dosage and Administration

Arodoxin Injection should only be administered by qualified healthcare professionals experienced in cancer chemotherapy.

General guidelines include:

• Administered by slow intravenous injection or infusion.
• Dosage is calculated based on body surface area (BSA), cancer type, and treatment regimen.
• Regular blood tests and clinical monitoring are required during treatment.
• Liver function and heart function should be assessed before and during therapy.
• Adequate hydration and supportive care may be recommended depending on the treatment plan.

Do not self-administer this medicine.

Possible Side Effects

Like most chemotherapy medicines, Arodoxin Injection may cause side effects, including:

• Nausea and vomiting
• Hair loss
• Fatigue
• Mouth sores (mucositis)
• Loss of appetite
• Diarrhea
• Red discoloration of urine for 1–2 days after treatment (a harmless and expected effect)

Serious side effects may include:

• Low white blood cell count (neutropenia)
• Anemia and thrombocytopenia
• Increased risk of infections
• Heart muscle damage (cardiotoxicity)
• Liver function abnormalities
• Tissue damage if the medicine leaks outside the vein (extravasation)

Seek immediate medical attention if you develop fever, chest pain, severe shortness of breath, unusual bleeding, or severe pain and swelling at the injection site.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

Before receiving Arodoxin Injection, inform your doctor if you:

• Have heart disease or a history of heart failure
• Have liver impairment
• Have previously received anthracycline chemotherapy
• Have active infections
• Are pregnant or planning to become pregnant
• Are breastfeeding

Additional precautions:

• Regular monitoring of heart function (such as echocardiography or MUGA scan) may be required during treatment due to the risk of cardiotoxicity.
• Frequent blood tests are necessary to monitor blood cell counts and liver function.
• Avoid live vaccines unless approved by your healthcare provider.
• Effective contraception is recommended during treatment and for an appropriate period afterward, as advised by your oncologist.

Storage

• Store according to the manufacturer's recommendations.
• Protect from light.
• Do not freeze.
• Keep out of reach of children.
• Store and handle only by trained healthcare professionals in appropriate medical facilities.